Pfizer-BioNTech vaccine could be ready for approval by mid-October: CEO
Arirang News
2020-09-09
Views 10
바이오엔테크 CEO "코로나 백신, 10월 중순 승인받을 준비될 것"
U.S. drug giant Pfizer and German firm BioNTech are positive their own COVID-19 vaccine candidates could be ready for approval by mid-October.
Speaking to CNN on Tuesday, BioNTech's CEO said their vaccine is near perfect.
He said approval for emergency use will be granted quickly by regulators.
He further added antibody responses in both young adults and the elderly have proven to be strong with minimal side effects.
Pfizer and BioNTech plan to provide a hundred million doses of the vaccine, BNT162, by the end of this year, and up to one-point-three billion doses in 2021.
U.S. drug giant Pfizer and German firm BioNTech are positive their own COVID-19 vaccine candidates could be ready for approval by mid-October.
Speaking to CNN on Tuesday, BioNTech's CEO said their vaccine is near perfect.
He said approval for emergency use will be granted quickly by regulators.
He further added antibody responses in both young adults and the elderly have proven to be strong with minimal side effects.
Pfizer and BioNTech plan to provide a hundred million doses of the vaccine, BNT162, by the end of this year, and up to one-point-three billion doses in 2021.
Report form
